Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Dal Negro

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPDR W Dal Negro
Respiration; International Review of Thoracic Diseases|August 19, 2011
The socioeconomic status of subjects: a prominent feature contributing to the phenotypical approach to COPDR W Dal Negro
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 9, 2009
Cultural and linguistic testing of the Handling Questionnaire: a specific instrument for assessing the patient's acceptability of dry powder inhalersR W Dal Negro, M Guerriero
Respiratory Medicine|September 27, 2017
Patient Related Outcomes-BODE (PRO-BODE): A composite index incorporating health utilization resources predicts mortality and economic cost of COPD in real lifeR W Dal Negro, B R Celli
International Journal of Clinical Pharmacology Research|January 1, 1984
Effects of orally administered cimetidine, ranitidine and oxmetidine on bronchomotor tone in normal volunteersR W Dal Negro, P Turco, O Zocatelli
European Annals of Allergy and Clinical Immunology|February 28, 2013
Pattern of airway inflammation and remodelling in mild persistent atopic asthma and in mild persistent asthma related to gastroesophageal refluxR W Dal Negro, M Guerriero, C Micheletto
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|March 21, 2012
Use of aerosols in bronchiectasis patientsR W Dal Negro, C Micheletto, S Tognella
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1983
A new spirometric parameter in clinical pharmacologyR W Dal Negro, P Turco, R Serra
Respiratory Medicine|July 29, 2018
Cost of influenza and influenza-like syndromes (I-LSs) in Italy: Results of a cross-sectional telephone survey on a representative sample of general populationR W Dal Negro, P Turco, M Povero
Pulmonary Pharmacology & Therapeutics|June 28, 2015
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trialR W Dal Negro, M Visconti, P Turco
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPDR W Dal Negro
Respiration; International Review of Thoracic Diseases|August 19, 2011
The socioeconomic status of subjects: a prominent feature contributing to the phenotypical approach to COPDR W Dal Negro
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 9, 2009
Cultural and linguistic testing of the Handling Questionnaire: a specific instrument for assessing the patient's acceptability of dry powder inhalersR W Dal Negro, M Guerriero
Respiratory Medicine|September 27, 2017
Patient Related Outcomes-BODE (PRO-BODE): A composite index incorporating health utilization resources predicts mortality and economic cost of COPD in real lifeR W Dal Negro, B R Celli
International Journal of Clinical Pharmacology Research|January 1, 1984
Effects of orally administered cimetidine, ranitidine and oxmetidine on bronchomotor tone in normal volunteersR W Dal Negro, P Turco, O Zocatelli
European Annals of Allergy and Clinical Immunology|February 28, 2013
Pattern of airway inflammation and remodelling in mild persistent atopic asthma and in mild persistent asthma related to gastroesophageal refluxR W Dal Negro, M Guerriero, C Micheletto
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|March 21, 2012
Use of aerosols in bronchiectasis patientsR W Dal Negro, C Micheletto, S Tognella
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1983
A new spirometric parameter in clinical pharmacologyR W Dal Negro, P Turco, R Serra
Respiratory Medicine|July 29, 2018
Cost of influenza and influenza-like syndromes (I-LSs) in Italy: Results of a cross-sectional telephone survey on a representative sample of general populationR W Dal Negro, P Turco, M Povero
Pulmonary Pharmacology & Therapeutics|June 28, 2015
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trialR W Dal Negro, M Visconti, P Turco
Pageof 4